Mission
The mission of Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, is to conduct cutting-edge research and translate the findings into new and improved therapies. The New Jersey Pediatric Hematology and Oncology Research Center of Excellence (NJ PHORCE) at Rutgers Cancer Institute was created in 2021, supported by the State of New Jersey, to ensure that children, adolescents, and young adults in New Jersey with cancer or blood disorders can benefit from research-driven improvements in treatment. NJ PHORCE aims to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy.
Vision
Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance scientific discovery and reduce the burden of childhood cancer and blood disorders. By engaging with and empowering our diverse populations and addressing their questions and fears, we will engender hope for patients and their families and play a critical role in strengthening the fabric of our communities.
Related News
$10M Appropriation from the State of New Jersey for Pediatric Cancer Will Help Advance Research and Treatment
This legislation will support the establishment of the Pediatric Cancer Center at Rutgers Cancer Institute which, in partnership with RWJBarnabas Health, is a leader in pediatric cancer research and care.
